Immunocore Holdings PLC at Barclays Global Healthcare Conference Transcript
Thank you so much. Welcome to Barclays Healthcare Conference -- Global Healthcare Conference in Miami and do e-mail us or reach us on Bloomberg, if you have any questions, I can get them message to me. My name is Peter Lawson. I'm one of the SMID Cap Biotech Analyst at Barclays and focused on oncology-related companies and really delighted to have up on stage with me management from Immunocore. We have Brian Di Donato, CFO; and David Berman, Head of R&D.
Questions & Answers
And I guess my first question really going to be around, I guess, revenue growth and kind of how we should be thinking about it? You've done a fantastic job with over the last 3, 4 quarters on accelerated growth. How long does that story continue for? And what are the pushes and takes that we should be thinking about as we enter 2023.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
